Clinical Trials · NCT06683066
Study on Human Bioequivalence of Triprerelin Acetate for Injection
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- The Affiliated Hospital of Qingdao University
- Enrollment
- 120
- Start date
- Dec 2024
- Locations
- 1 site, China
- Primary endpoint
- Peak Plasma Concentration (Cmax)